Nigeria's MR and HPV Vaccine Rollout Achieves Milestone

Nigeria's rollout of the Measles-Rubella (MR) and Human Papillomavirus (HPV) vaccines marks a significant public health milestone, showcasing the country's ability to enhance its routine immunization system. Despite persistent challenges, measles remains a leading cause of preventable illness and death among children, while HPV continues to claim thousands of Nigerian women's lives annually.

The introduction of the MR and HPV vaccines represents a decisive step in addressing these long-standing public health issues. Initial awareness of the MR vaccine was low, with only 7% of Nigerians aware as of April 2025, but advocacy efforts increased this to 61% by March 2026.

The campaign reached approximately 58 million people, with 150,656 girls vaccinated, achieving 96% MR coverage among target children. The initiative was supported by strong leadership from the governor and first lady, alongside the National Primary Health Care Development Agency (NPHCDA) and community leaders, emphasizing the need for sustained demand and ongoing awareness to ensure consistent vaccine uptake.